BIOBASE GmbH and DNASTAR’s software achieved Affymetix GeneChip compatibility. In June, Illumina made available the open-access iControlDB genotyping-control repository. OGT launched the CytoSure Syndrome Plus and Chromosome X exon specific CGH arrays for cytogenetics.
In May, Affymetrix opened a manufacturing facility in Singapore. ChannelNewsAsia reports that the facility will manufacture 30% of the company’s products and has a staff of 124. Affymetrix appointed John C. Batty CFO and executive vice president in June. He previously served as senior vice president of finance and CFO of Credence Systems. In July, […]
Epigenetics, which is the study of different factors that influence gene regulation, has become one of the hottest applications in genomic research. Basically, researchers in epigenetics are trying to understand the mechanisms that govern cell activity and differentiate cell phenotypes. For example, eye and skin cells behave differently despite having the same genetic makeup. This […]
In the second quarter of 2007, revenues for IBO’s Laboratory Sales Index grew a robust 13.8% to $4,083 million. Operating profit jumped 29.3% to $631 million, and operating margin climbed 190 basis points to 15.5% of sales. Strong organic and acquisition-related growth from Thermo Fisher Scientific, Bruker BioSciences, PerkinElmer and Agilent helped boost revenues and […]
GenTel BioSciences announced in March that it acquired GlaxoSmithKline’s protein chip platform assets. Affymetrix launched the Collaborations in Cancer Research Program, an alliance with 30 European cancer researchers. Later this year, the Program will be expanded to North America and Japan. In April, Affymetrix and NuGEN Technologies announced a comarketing agreement for NuGEN’s WT-Ovation FFPE […]
febit launched a Geniom Biochip for all known microRNA sequences, available as a Ready-To-Go-Biochip or made on site by the company’s Geniom One instrument. In May, febit introduced the Geniom RT Analyzer for sample hybridization, automated processing and analysis for multiple applications, including multiplex amplification on a chip and dynamic detection. Geniom Biochips can be […]
Biotools B&M Labs SA released CapitalBio’s microarray platform to the Spanish market and provided CapitalBio with its LIONPROBES real-time amplification technology, the Gelification stabilization platform and recombinant enzymes for kits and reagents for the Chinese market. Oxford Gene Technology and Integrated Genomics partnered to develop and market a Pichia pastoris gene expression oligonucleotide microarray. In […]
Illumina launched the HumanCNV370-Duo DNA Analysis BeadChip, developed in collaboration with deCODE genetics, to target novel regions of the genome that show copy number variation. It enables the analysis of two samples simultaneously. Illumina released the BeadXpress System detection platform, based on VeraCode digital microbead technology, for low to mid-multiplex experiments. Illumina launched a custom-content […]
Company Announcements Affymetrix promoted James Gibson, vice president of accounting and corporate controller, to principal accounting officer in December 2006. In January, Illumina signed a collaborative agreement with the Mayo Clinic to codevelop molecular diagnostic tests for the study of complex diseases. Partek’s Genomics Suite achieved GeneChip-compatible status for analysis of SNP association studies using […]
Company Announcements NimbleGen Systems named Gregory McGuinness as vice president of International Business. He was previously director of European Business Development for Gene Logic. NimbleGen Systems obtained a license to the “Southern array patents” from Oxford Gene Technology (OGT) and will supply OGT with microarrays for use in its service business. Oxford Gene Technology granted […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
